GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NKY Medical Holdings Ltd (SZSE:300109) » Definitions » Total Assets

NKY Medical Holdings (SZSE:300109) Total Assets : ¥4,110 Mil (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is NKY Medical Holdings Total Assets?

NKY Medical Holdings's Total Assets for the quarter that ended in Mar. 2024 was ¥4,110 Mil.

During the past 12 months, NKY Medical Holdings's average Total Assets Growth Rate was 16.90% per year. During the past 3 years, the average Total Assets Growth Rate was -1.80% per year. During the past 5 years, the average Total Assets Growth Rate was 5.40% per year. During the past 10 years, the average Total Assets Growth Rate was 25.70% per year.

During the past 13 years, NKY Medical Holdings's highest 3-Year average Total Assets Growth Rate was 54.00%. The lowest was -7.10%. And the median was 37.80%.

Total Assets is connected with ROA %. NKY Medical Holdings's annualized ROA % for the quarter that ended in Mar. 2024 was 11.95%. Total Assets is also linked to Revenue through Asset Turnover. NKY Medical Holdings's Asset Turnover for the quarter that ended in Mar. 2024 was 0.10.


NKY Medical Holdings Total Assets Historical Data

The historical data trend for NKY Medical Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKY Medical Holdings Total Assets Chart

NKY Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,196.72 4,179.25 3,875.13 3,713.70 4,019.69

NKY Medical Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,793.41 3,740.39 3,970.86 4,019.69 4,109.82

NKY Medical Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

NKY Medical Holdings's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=3520.031+499.661
=4,020

NKY Medical Holdings's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=3648.238+461.583
=4,110

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NKY Medical Holdings  (SZSE:300109) Total Assets Explanation

Total Assets is connected with ROA %.

NKY Medical Holdings's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=485.548/( (4019.691+4109.82)/ 2 )
=485.548/4064.7555
=11.95 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

NKY Medical Holdings's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=394.688/( (4019.691+4109.82)/ 2 )
=394.688/4064.7555
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

NKY Medical Holdings Total Assets Related Terms

Thank you for viewing the detailed overview of NKY Medical Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


NKY Medical Holdings (SZSE:300109) Business Description

Traded in Other Exchanges
N/A
Address
No.9 Zhongshan Road, Boai county, Jiaozuo, Henan, CHN, 454450
NKY Medical Holdings Ltd develops and manufactures polyvinylpyrrolidone (PVP) series products in China. Its products can be used in Pharmaceutical accessories, hair gel, wine products stabilizer, water treatment, glue stick, and oral care products.
Executives
Zhang Jun Zheng Directors, executives
Yang Hong Bo Director
Wang Dong Hu Director
Ren Da Long Director
Xing Xiao Liang Directors, executives
Zou Xiao Wen Executives
Wang Shi Gang Executives
Wang Xin Meng Executives
Qu Yun Xia Supervisors
Wang Jian Qiang Director
Yang Hai Jiang Director
Yan Zhong Chao Supervisors
Liu Ai Min Executives
Wu Cong Zhou Executives
Wu Wen Bin Director

NKY Medical Holdings (SZSE:300109) Headlines

No Headlines